Puri Raj K. 4
4 · IOVANCE BIOTHERAPEUTICS, INC. · Filed Mar 18, 2025
Insider Transaction Report
Form 4
Puri Raj K.
Chief Regulatory Officer
Transactions
- Tax Payment
Common Stock
2025-03-14$3.59/sh−2,509$9,007→ 201,252 total - Exercise/Conversion
Common Stock
2025-03-14+8,334→ 203,761 total - Exercise/Conversion
Restricted Stock Units
2025-03-14−8,334→ 0 total→ Common stock (8,334 underlying)
Footnotes (6)
- [F1]Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.
- [F2]Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
- [F3]Represents the common stock remaining after deducting the common stock withheld for taxes.
- [F4]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F5]The remaining RSUs will vest in equal quarterly installments.
- [F6]Such aggregate number reflects the remainder of such RSUs granted on March 14, 2022, but does not include any other RSUs held by such Reporting Person.